Lyfegen Revenue and Competitors

Basel,

Location

$17M

Total Funding

Estimated Revenue & Valuation

  • Lyfegen's estimated annual revenue is currently $5.1M per year.(i)
  • Lyfegen's estimated revenue per employee is $116,000
  • Lyfegen's total funding is $17M.

Employee Data

  • Lyfegen has 44 Employees.(i)
  • Lyfegen grew their employee count by 22% last year.

Lyfegen's People

NameTitleEmail/Phone
1
CEO, FounderReveal Email/Phone
2
CEO & FounderReveal Email/Phone
3
CFO, Co-FounderReveal Email/Phone
4
Global VP Sales and Business DevelopmentReveal Email/Phone
5
VP Sales & Business DevelopmentReveal Email/Phone
6
Head TechnologyReveal Email/Phone
7
Chief Customer Experience Officer & FounderReveal Email/Phone
8
Director, Sales & Business Development CanadaReveal Email/Phone
9
Product OwnerReveal Email/Phone
10
Business Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$60M33124%N/AN/A
#2
$5.3M46-6%N/AN/A
#3
$36.8M236-3%$46.9MN/A
#4
$15.1M1044%N/AN/A
#5
$1.4M16-6%N/AN/A
#6
$1.4M16-6%N/AN/A
#7
$3.5M30-12%N/AN/A
#8
$146M7196%N/AN/A
#9
$99.7M550-1%N/AN/A
#10
$12.9M89-3%$3.5MN/A
Add Company

What Is Lyfegen?

Lyfegen helps patients to access cutting edge, high-cost therapies with our groundbreaking value-based contracting platform. Our solutions provide manufacturers, healthcare payers, and healthcare providers the tools needed to execute value-based and data-driven agreements. Our Solutions Lyfevalue: Bringing manufacturers and healthcare payers together in outcome-based contracting as no platform has ever before. Lyfeapp: Giving healthcare professionals an innovative patient management solution to collect and analyze patient data securely. Discover more and book a demo on our website lyfegen.com

keywords:N/A

$17M

Total Funding

44

Number of Employees

$5.1M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.9M447%N/A
#2
$7.7M44-30%N/A
#3
$6.7M489%N/A
#4
$5.5M490%N/A
#5
$7M5019%N/A